PharmaKnowl Consulting is pleased to announce our participation as an exhibitor at the World Patient Safety Congress Europe 2026, taking place on 23–24 September 2026 at the RAI Amsterdam, Netherlands.
📍 Visit us at Booth 10.525
The World Patient Safety Congress Europe is a leading international event dedicated to improving patient safety across healthcare and the life sciences industry. The congress brings together pharmaceutical companies, biotechnology organizations, regulators, healthcare providers, technology innovators, and patient safety experts to discuss the latest developments in pharmacovigilance, drug safety, risk management, and regulatory compliance. It provides a platform for sharing best practices, exploring emerging technologies, and strengthening collaboration to enhance patient outcomes worldwide.
As an SFDA-licensed regulatory consulting firm based in Saudi Arabia, PharmaKnowl Consulting supports pharmaceutical and biotechnology companies in building and maintaining robust pharmacovigilance systems that meet both local and international regulatory expectations. Our team of experienced pharmacovigilance specialists works closely with global organizations to ensure continuous compliance while helping safeguard patient health throughout the product lifecycle.
During the congress, our experts will be available to discuss how PharmaKnowl can support your organization with:
- Complete pharmacovigilance solutions, including Local QPPV services, Pharmacovigilance System Master File (PSMF) preparation and maintenance, Individual Case Safety Report (ICSR) processing, literature monitoring, signal detection, aggregate reporting, Risk Management Plans (RMPs), and ongoing compliance support.
- SFDA pharmacovigilance compliance for companies marketing medicinal products in Saudi Arabia, helping ensure regulatory obligations are met efficiently and confidently.
- Pharmacovigilance system implementation and optimization, enabling organizations to establish scalable, inspection-ready PV systems aligned with SFDA requirements and international Good Pharmacovigilance Practices (GVP).
- Strategic pharmacovigilance consulting, helping companies strengthen safety governance, prepare for inspections, address compliance gaps, and effectively manage evolving regulatory requirements.
Whether you are preparing to enter the Saudi market, looking for a trusted Local QPPV, strengthening your global pharmacovigilance operations, or seeking expert guidance on SFDA compliance, our specialists are ready to discuss practical solutions tailored to your organization’s needs.
👉 Visit us at Booth 10.525 to meet our pharmacovigilance experts, discuss your regulatory and patient safety challenges, and discover how PharmaKnowl Consulting can help you build compliant, efficient, and patient-focused pharmacovigilance systems for Saudi Arabia and the GCC.
About the Author
Contributed by the PharmaKnowl regulatory affairs team, based in Riyadh. Written and reviewed by our SFDA-experienced consultants.
Resources
Services
Events
